SynuSight is a pioneering biotech company committed to unraveling the complexities of neurodegenerative diseases. We specialize in the in-depth investigation of the misfolding and aggregation of key pathological proteins such as α-syn, tau, and Aβ. By leveraging a suite of cutting-edge technologies like cryo-EM, in-cell NMR, and AIDD, we have established innovative pipelines including the α-syn PET tracer, targeting the critical mechanisms underlying neurodegenerative disorders.

SynuSight Biotech

Org chart

Teams

Offices